Immatics (IMTX) Retained Earnings (2019 - 2025)
Immatics (IMTX) reported Retained Earnings of -$10.0 million for Q4 2025, down 1007.8% on a YoY basis from $1.1 million in Q4 2024, and down 5.53% sequentially from -$9.5 million in Q3 2025.
Immatics (IMTX) Retained Earnings (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Retained Earnings data on file, last reported at -$10.0 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 1007.8% year-over-year to -$10.0 million; the trailing twelve-month figure through Dec 2025 stood at -$10.0 million (down 1007.8% YoY), and the FY2025 full-year result was -$9.7 million, down 969.92% from the prior year.
- Retained Earnings slipped to -$10.0 million in Q4 2025, from -$9.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.1 million in Q4 2024 to a low of -$673.0 million in Q2 2024.
- A 5-year average of -$126.6 million and a median of -$4.8 million in 2022 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 162.59% in 2024, while the deepest fall reached 66897.06% in 2024.
- Tracing IMTX's Retained Earnings over 5 years: stood at -$615.2 million in 2021, then increased by 15.41% to -$520.4 million in 2022, then jumped by 99.66% to -$1.8 million in 2023, then jumped by 162.59% to $1.1 million in 2024, then sank by 1007.8% to -$10.0 million in 2025.
- Business Quant data shows IMTX's Retained Earnings at -$10.0 million in Q4 2025, -$9.5 million in Q3 2025, and -$8.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | -10.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.00 Mn |
| Sep 30, 2025 | -9.48 Mn |
| Jun 30, 2025 | -8.50 Mn |
| Mar 31, 2025 | -1.77 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | -2.43 Mn |
| Jun 30, 2024 | -673.05 Mn |
| Mar 31, 2024 | -659.42 Mn |
| Dec 31, 2023 | -1.76 Mn |
| Sep 30, 2023 | -775,076.42 |
| Jun 30, 2023 | -1.24 Mn |
| Mar 31, 2023 | -984,254.45 |
| Dec 31, 2022 | -520.44 Mn |
| Sep 30, 2022 | -2.84 Mn |
| Jun 30, 2022 | -2.78 Mn |
| Mar 31, 2022 | -3.80 Mn |
| Dec 31, 2021 | -615.24 Mn |
| Sep 30, 2021 | -5.76 Mn |
| Jun 30, 2021 | -7.39 Mn |
| Mar 31, 2021 | -5.71 Mn |